Company Spotlight | Healthcare & Pharmaceuticals

Acadia: Multiple Data Points Suggest Further Upside In The Stock

Acadia Pharmaceuticals (ACAD) has to be one of the top performing stocks over the past year with a chart…

From Seeking Alpha | 1 hour ago

Actavis Buys Warner Chilcott, Upside Seems Limited

On May 21, 2013, Actavis (ACT) announced that it would acquire Warner Chilcott (WCRX) for $20.08 per…

From Seeking Alpha | 2 hours ago

2 Healthcare Companies With Recent Intensive Insider Buying

The healthcare sector has been the best-performing sector YTD with a gain of 22.3%. (click to enlarge)…

From Seeking Alpha | 4 hours ago

United Therapeutics: A Growth Stock With Good Products And A Promising Pipeline

United Therapeutics (UTHR) is a biopharmaceutical company which develops and markets products for patients…

From Seeking Alpha | 4 hours ago

A Review Of Upcoming Catalysts For Kidney Disease Biotech Players In 2013

With a potential U.S. market for Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD)…

From Seeking Alpha | 4 hours ago

Amarin Stays Rangebound, Prescriptions Stagnate

Amarin Corporation (NASDAQ: AMRN) has been struggling a lot lately as retail channel prescription data…

From Seeking Alpha | 6 hours ago

Vivus Heats Up, Shorts Discouraged On Possible Bidding War

Vivus (NASDAQ: VVUS) has been seeing relatively modest growth in Qsymia (phentermine and topiramate…

From Seeking Alpha | 7 hours ago

Dividend Growth Gem Medtronic Is A Cash Cow

Dividend Growth Newsletter holding Medtronic (MDT) reported wonderful fourth quarter results. Revenue…

From Seeking Alpha | 8 hours ago

Amgen: Financial Analysis And Valuation

Overview Amgen, Inc. (AMGN) incorporated in 1980 is a global biotechnology company that discovers, develops,…

From Seeking Alpha | 9 hours ago

Arena - Good Sales, Bad Sales, Long And Short

When the discussion turns to Arena Pharmaceuticals (ARNA) there is no shortage of opinion, passion,…

From Seeking Alpha | 10 hours ago

Actavis To Increase Operational Synergies By Acquiring Warner

The pharmaceutical industry is one of the biggest industries in the world. Currently the global pharmaceutical…

From Seeking Alpha | 10 hours ago

Pfizer Has Potential To Grow Despite Decreasing Sales

Pfizer (PFE) is the world's largest research-based pharmaceutical company. It discovers, manufactures…

From Seeking Alpha | 10 hours ago

First Manhattan Still Playing Hardball With Vivus

First Manhattan, an investor with about a 10% stake in Vivus (VVUS), has now taken the step of increasing…

From Seeking Alpha | 12 hours ago

Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy

The annual conference of The American Society of Clinical Oncology (ASCO) is currently less than a few…

From Seeking Alpha | 19 hours ago

Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback

Shares of Johnson & Johnson (JNJ) have been in a solid uptrend throughout 2013. As shown in the…

From Seeking Alpha | 21 hours ago

Why Merck Shares Are Cheap And Could Rise To $60

While many stocks are trading near 52-week highs or at stretched valuations, investors who selectively…

From Seeking Alpha | 21 hours ago

Arena Is Still A Great Short

At the recent Bank of America Merrill Lynch 2013 Health Care Conference, Craig Audet Ph.D. gave an overview…

From Seeking Alpha | 21 hours ago

Expanding Use Of Alexion's Specialty Drug Soliris Offers Upside

Ultra rare diseases have become big business for both pharmaceutical and biotechnology companies, such…

From Seeking Alpha | 23 hours ago

Arena Buyout More 'Highly Probable' Than MannKind

I was compelled to compare the buyout prospect of Arena Pharmaceuticals (ARNA) with MannKind Corporation…

From Seeking Alpha | 23 hours ago

Another Look At Marketing Vs. R&D In Pharma

FiercePharma has some good figures to back up my posts the other day on R&D spending versus marketing.…